News
-
-
-
PRESS RELEASE
Agnostiq Partners With Nexgen Cloud’s Hyperstack Platform To Increase Covalent Cloud’s GPU Capacity
Agnostiq, Inc. has integrated NexGen Cloud's Hyperstack GPU compute resources into its Covalent Cloud offering, significantly increasing the amount of GPU resources available and making premium GPU hardware more accessible to end-users. This collaboration empowers innovative startups to create cutting-edge AI applications while democratizing accelerated computing access worldwide. The partnership delivers top-tier hardware, capacity, availability, and user-friendliness, marking a significant step towards fulfilling the mission of both companies. -
-
-
PRESS RELEASE
Agnostiq Closes $6.1 Million Seed Extension Round
![Accesswire](/assets/images/accesswire-inline.png)
-
University of York Chooses Alces Flight to Boost Sustainable Research
-
Alset Capital Inc. Announces AI GPU Contract with a $91.7M Option Signed by Investee Company Cedarcross
-
Ivanhoe Electric Clarifies Certain Misleading Media Headlines Regarding Its Recent Registration Statement Filing
-
FE Battery Metals Announces Positive Laboratory Results Producing Lithium Carbonate Grades Exceeding 99% Purity
-
SouthGobi Announces Update on Mongolia Tax Audit
![EQS Group](/assets/images/eqs-group.png)
-
Dr Ingo Mantzke has resigned as Chairman of the Advisory Board of Swiss Merchant Group AG
-
Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Buy
-
MGI – Media and Games Invest SE held its Annual General Meeting
-
Mililk® now available at Penny
-
TUI AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
![Les Echos](/assets/images/les-echos.png)
-
Moody’s reaffirms « A1 » Outlook Stable rating of CNP Assurances SA
-
EURAZEO OPENS AN OFFICE IN TOKYO, FURTHER EXTENDING ITS INTERNATIONAL REACH
-
imerys-12-06-2024-implementation-of-the-share-buyback-program
-
COGELEC : Statement on the total number of shares and voting rights.
-
Biophytis announces the successful industrial transfer of BIO101 (20-hydroxyecdysone) production by its service provider Seqens